Sellas Life Sciences (NASDAQ: SLS)

Sellas Life Sciences SLS Stock News
Sellas Life Sciences official logo.

Sellas Life Sciences Group Inc (NASDAQ: SLS) is an immuno-pharmaceutical company. At the moment the company is in late stage clinical development with its flagship product, galinpepimut-S, also known as GPS.

GPS is being developed as a potential clinical option to treat various types of cancer. On June 19, 2019, the company announced that it received funding to move into a pivotal study of GPS as a result of a public offering of common stock and warrants. 

Visit the Sellas Life Sciences investor relations website here

Sellas Life Sciences (NASDAQ: SLS) Reports From Alpha Stock News